基于机器学习的抗菌药物选择个性化指南探索
该回顾性观察研究利用英国伯明翰2010年1月至2016年10月的常规临床数据,训练开源机器学习算法XGBoost预测大肠埃希菌、肺炎克雷伯菌和铜绿假单胞菌对阿莫西林/克拉维酸和哌拉西林/他唑巴坦的耐药性。结论认为机器学习有潜力辅助预测耐药,但需前瞻性验证。
要点
- 机器学习算法预测革兰阴性菌耐药性的AUC为0.70,仅略优于评分工具。
- 在已使用特定广谱抗生素的患者中,该算法可能减少高达40%的不必要使用。
- 需前瞻性研究验证其在未经选择患者中的表现及临床可接受性。
核心结论
- 机器学习算法有潜力帮助临床医生预测血液或尿液革兰阴性菌感染的耐药性。
研究设计与样本
- 回顾性观察研究,使用英国伯明翰2010年1月至2016年10月的常规临床数据。
主要发现
- 评分工具预测耐药的AUC范围为0.61至0.67,在选择合适抗生素方面不优于医务人员。
- 机器学习系统XGBoost的AUC为0.70,统计上略优,并可能减少高达40%的不必要广谱抗生素使用(针对已使用阿莫西林/克拉维酸、哌拉西林/他唑巴坦或碳青霉烯类者)。
临床怎么用
- 机器学习算法可作为辅助工具预测革兰阴性菌耐药性,但需前瞻性验证后再用于临床决策。
局限性
- 需要前瞻性研究评估算法在未经选择患者队列中的表现、临床可接受性及对患者结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Electronic decision support systems could reduce the use of inappropriate or ineffective empirical antibiotics. We assessed the accuracy of an open-source machine-learning algorithm trained in predicting antibiotic resistance for three Gram-negative bacterial species isolated from patients' blood and urine within 48 h of hospital admission. METHODS: This retrospective, observational study used routine clinical information collected between January 2010 and October 2016 in Birmingham, UK. Patients from whose blood or urine cultures Escherichia coli, Klebsiella pneumoniae or Pseudomonas aeruginosa was isolated were identified. Their demographic, microbiology and prescribing data were used to train an open-source machine-learning algorithm-XGBoost-in predicting resistance to co-amoxiclav and piperacillin/tazobactam. Multivariate analysis was performed to identify predictors of resistance and create a point-scoring tool. The performance of both methods was compared with that of the original prescribers. RESULTS: There were 15 695 admissions. The AUC of the receiver operating characteristic curve for the point-scoring tools ranged from 0.61 to 0.67, and performed no better than medical staff in the selection of appropriate antibiotics. The machine-learning system performed statistically but marginally better (AUC 0.70) and could have reduced the use of unnecessary broad-spectrum antibiotics by as much as 40% among those given co-amoxiclav, piperacillin/tazobactam or carbapenems. A validation study is required. CONCLUSIONS: Machine-learning algorithms have the potential to help clinicians predict antimicrobial resistance in patients found to have a Gram-negative infection of blood or urine. Prospective studies are required to assess performance in an unselected patient cohort, understand the acceptability of such systems to clinicians and patients, and assess the impact on patient outcome.
引用
- Moran E, Robinson E, Green C, et al. Towards personalized guidelines: using machine-learning algorithms to guide antimicrobial selection. J Antimicrob Chemother. 2020. PMID: 32542387. doi:10.1093/jac/dkaa222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。